Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | IDXX | Common Stock | 10 | Feb 14, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Award | +5.04K | 5.04K | Feb 14, 2022 | Common Stock | 5.04K | $505.53 | Direct | F2, F6 | |||
transaction | IDXX | Incentive Stock Option (right-to-buy) | Award | +197 | 197 | Feb 14, 2022 | Common Stock | 197 | $505.53 | Direct | F3, F6 | |||
transaction | IDXX | Restricted Stock Unit | Award | +593 | +801.35% | 667 | Feb 14, 2022 | Common Stock | 593 | Direct | F4, F6 | |||
transaction | IDXX | Restricted Stock Unit | Award | +593 | +88.91% | 1.26K | Feb 14, 2022 | Common Stock | 593 | Direct | F5, F6 |
Id | Content |
---|---|
F1 | Includes 10 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2021. |
F2 | Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023. |
F3 | Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. |
F4 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
F5 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in one installment on February 14, 2025. |
F6 | Not applicable. |